IDEXX Laboratories (NASDAQ:IDXX) shares jumped on Monday after the company raised its full year revenue and profit guidance, banking on rising demand for its inVue Dx instrument placements. It lifted ...
In the last three months, 6 analysts have published ratings on IDEXX Laboratories (NASDAQ:IDXX), offering a diverse range of perspectives from bullish to bearish. The following table encapsulates ...
May 1 (Reuters) - Animal diagnostics maker IDEXX Laboratories (IDXX.O), opens new tab on Thursday raised its annual profit forecast after it beat Wall Street estimates for quarterly profit, as it ...
Aug 4 (Reuters) - IDEXX Laboratories (IDXX.O), opens new tab raised its full-year profit and revenue forecasts on Monday after reporting better-than-expected second-quarter results, sending its shares ...
IDEXX Laboratories IDXX has shown remarkable momentum so far this year, climbing 52.9%. The stock has comfortably surpassed the industry’s 12.9% fall and the S&P 500 Composite’s 13.8% gain. Carrying a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback